Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study

LD Dillon, M McPhee, RS Davidson… - Current Medical …, 2022 - Taylor & Francis
Abstract Objective National Comprehensive Cancer Network (NCCN) guidelines for
cutaneous melanoma (CM) recommend physicians consider increased surveillance for …
被引用次数：12 相关文章

Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study

LD Dillon, M McPhee, RS Davidson… - Current Medical …, 2022 - ohsu.elsevierpure.com
Objective: National Comprehensive Cancer Network (NCCN) guidelines for cutaneous
melanoma (CM) recommend physicians consider increased surveillance for patients who …

Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.

LD Dillon, M McPhee, RS Davidson… - Current Medical …, 2022 - europepmc.org
Objective National Comprehensive Cancer Network (NCCN) guidelines for cutaneous
melanoma (CM) recommend physicians consider increased surveillance for patients who …

Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study

LD Dillon, M McPhee, RS Davidson… - Current medical …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective National Comprehensive Cancer Network (NCCN) guidelines for cutaneous
melanoma (CM) recommend physicians consider increased surveillance for patients who …

Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study

LD Dillon, M McPhee, RS Davidson… - … Medical Research & …, 2022 - ingentaconnect.com
Objective National Comprehensive Cancer Network (NCCN) guidelines for cutaneous
melanoma (CM) recommend physicians consider increased surveillance for patients who …